Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Posterior reversible encephalopathy syndrome due to combination of vemurafenib and cobimetinib for metastatic melanoma

Published:2017-03 Issue:2 Volume:30 Page:262-264
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Boukari Feriel¹,Dugourd Pierre Michel¹,Chassang Madleen²,Mondot Lydiane³,Passeron Thierry¹⁴,Lacour Jean-Philippe¹,Montaudie Henri¹

Affiliation:

1. Department of Dermatology; University of Nice Sophia Antipolis; Nice France

2. Department of Radiology; University of Nice Sophia Antipolis; Nice France

3. Department of Radiology; Pasteur Hospital; University of Nice Sophia Antipolis; Nice France

4. INSERM, U1065; Centre Méditerranéen de Médecine Moléculaire, Team 12; Nice France

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12562/fullpdf

Reference10 articles.

1. Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia

2. Acute encephalopathy with combination dabrafenib/trametinib therapy;Cooper;J. Oncol. Pharm. Pract.,2016

3. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions;Fugate;Lancet Neurol.,2015

4. Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!;Khurana;J. Oncol. Pharm. Pract.,2015

5. Posterior reversible encephalopathy syndrome (PRES) with immune system activation, VEGF up-regulation, and cerebral amyloid angiopathy;Kofler;J. Comput. Assist. Tomogr.,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Altered Mental Status in Cancer;Seminars in Neurology;2024-08-05

2. Posterior Reversible Encephalopathy Syndrome after Lenvatinib Therapy in a Patient with Olfactory Neuroblastoma;Brain Sciences;2022-12-23

3. Mepolizumab-Induced Posterior Reversible Encephalopathy Syndrome (PRES), a new patient report;BMC Neurology;2022-08-25

4. Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2019-12-09

5. Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndrome;Annals of Oncology;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3